Drugs / AK 3012
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01757613 Comparator | Dec 2012 → Jan 2014 | actinic keratosis | Dolorgiet GmbH & Co. KG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AK 3012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01757613 ↗ |
| Route | Topical | “cutaneous use twice a day” NCT01757613 ↗ |